ALB and rectal cancer: In this cohort, we found that “lymphocyte × albumin (LA)”, the product of the lymphocyte count multiplied by the albumin concentration, was particularly associated with rectal cancer patients’ prognosis; thus, we further explored the potential feasibility of the newly developed factor, “LA”, as a prognostic marker in the external validation cohort.